The feasibility, reliability and concurrent validity of the MSReactor computerized cognitive screening tool in multiple sclerosis

by Daniel Merlo, David Darby, Tomas Kalincik, Helmut Butzkueven, Anneke van der Walt
Published 2019-07-01

Volumetric MRI markers and predictors of disease activity in early multiple sclerosis: a longitudinal cohort study.

by Tomas Kalincik, Manuela Vaneckova, Michaela Tyblova, Jan Krasensky, Zdenek Seidl, Eva Havrdova, Dana Horakova
Published 2012-01-01

Impairment of smooth pursuit as a marker of early multiple sclerosis

by Nathaniel Lizak, Nathaniel Lizak, Nathaniel Lizak, Meaghan Clough, Meaghan Clough, Lynette Millist, Tomas Kalincik, Tomas Kalincik, Owen B White, Owen B White, Owen B White, Joanne Fielding, Joanne Fielding, Joanne Fielding
Published 2016-11-01

Correction to: Comparison of the effectiveness of a tailored cognitive behavioural therapy with a supportive listening intervention for depression in those newly diagnosed with mul...

by Litza Kiropoulos, Trevor Kilpatrick, Tomas Kalincik, Leonid Churilov, Elizabeth McDonald, Tissa Wijeratne, Jennifer Threader, Vanja Rozenblat, Neil O’Brien-Simpson, Anneke Van Der Walt, Lisa Taylor
Published 2020-03-01

Peripheral Immune Cell Ratios and Clinical Outcomes in Seropositive Autoimmune Encephalitis: A Study by the Australian Autoimmune Encephalitis Consortium

by James Broadley, James Broadley, Robb Wesselingh, Robb Wesselingh, Udaya Seneviratne, Udaya Seneviratne, Udaya Seneviratne, Chris Kyndt, Chris Kyndt, Paul Beech, Paul Beech, Katherine Buzzard, Katherine Buzzard, Cassie Nesbitt, Cassie Nesbitt, Wendyl D’Souza, Wendyl D’Souza, Amy Brodtmann, Amy Brodtmann, Tomas Kalincik, Tomas Kalincik, Helmut Butzkueven, Helmut Butzkueven, Terence J. O’Brien, Terence J. O’Brien, Mastura Monif, Mastura Monif, Mastura Monif, Mastura Monif, Australian Autoimmune Encephalitis Consortium
Published 2021-01-01

Brain atrophy and lesion burden are associated with disability progression in a multiple sclerosis real-world dataset using only T2-FLAIR: The NeuroSTREAM MSBase study

by Michael Barnett, Niels Bergsland, Bianca Weinstock-Guttman, Helmut Butzkueven, Tomas Kalincik, Patricia Desmond, Frank Gaillard, Vincent van Pesch, Serkan Ozakbas, Juan Ignacio Rojas, Cavit Boz, Ayse Altintas, Chenyu Wang, Michael G. Dwyer, Suzie Yang, Dejan Jakimovski, Kain Kyle, Deepa P. Ramasamy, Robert Zivadinov
Published 2021-01-01

Environmental factors associated with disease progression after the first demyelinating event: results from the multi-center SET study.

by Dana Horakova, Robert Zivadinov, Bianca Weinstock-Guttman, Eva Havrdova, Jun Qu, Miriam Tamaño-Blanco, Darlene Badgett, Michaela Tyblova, Niels Bergsland, Sara Hussein, Laura Willis, Jan Krasensky, Manuela Vaneckova, Zdenek Seidl, Petra Lelkova, Michael G Dwyer, Ming Zhang, Haoying Yu, Xiaotao Duan, Tomas Kalincik, Murali Ramanathan
Published 2013-01-01

Persistence on therapy and propensity matched outcome comparison of two subcutaneous interferon beta 1a dosages for multiple sclerosis.

by Tomas Kalincik, Timothy Spelman, Maria Trojano, Pierre Duquette, Guillermo Izquierdo, Pierre Grammond, Alessandra Lugaresi, Raymond Hupperts, Edgardo Cristiano, Vincent Van Pesch, Francois Grand'maison, Daniele La Spitaleri, Maria Edite Rio, Sholmo Flechter, Celia Oreja-Guevara, Giorgio Giuliani, Aldo Savino, Maria Pia Amato, Thor Petersen, Ricardo Fernandez-Bolanos, Roberto Bergamaschi, Gerardo Iuliano, Cavit Boz, Jeannette Lechner-Scott, Norma Deri, Orla Gray, Freek Verheul, Marcela Fiol, Michael Barnett, Erik van Munster, Vetere Santiago, Fraser Moore, Mark Slee, Maria Laura Saladino, Raed Alroughani, Cameron Shaw, Krisztian Kasa, Tatjana Petkovska-Boskova, Leontien den Braber-Moerland, Joab Chapman, Eli Skromne, Joseph Herbert, Dieter Poehlau, Merrilee Needham, Elizabeth Alejandra Bacile Bacile, Walter Oleschko Arruda, Mark Paine, Bhim Singhal, Steve Vucic, Jose Antonio Cabrera-Gomez, Helmut Butzkueven, MSBase Study Group
Published 2013-01-01